
ANGO+66.67%11.1%

ARAY-82.33%11.1%

AXGN+209.96%11.1%

BVS+88.22%11.1%

BWAY-3.03%11.1%

CVRX-63.59%11.1%

NPCE+56.06%11.1%

OBIO+110.20%11.1%

STIM-11.76%11.1%
As of Aug 24, 2026, 4:53 AM ET
MedTech Long '25: Neuromodulation & Neurotechnology Devices Constituents
Accuray IncorporatedARAY | 11.1% | -3.90% | -3.10% | 17.08% | 4.07% | -65.92% | -51.34% | -84.56% | -87.72% | -93.12% | -82.33% | $33.3M |
AngioDynamics, Inc.ANGO | 11.1% | -0.44% | 0.00% | 15.89% | 6.49% | 22.66% | 37.67% | 45.03% | 105.08% | -43.39% | 66.67% | $651.0M |
AxoGen, Inc.AXGN | 11.1% | 8.53% | 3.96% | 27.63% | 19.40% | 53.99% | 58.84% | 184.91% | 302.56% | 210.15% | 209.96% | $2.71B |
Bioventus Inc.BVS | 11.1% | 0.35% | 3.83% | 21.86% | 9.19% | 93.28% | 63.78% | 51.21% | 44.96% | -6.68% | 88.22% | $974.2M |
BrainsWay Ltd.BWAY | 11.1% | -1.54% | -1.60% | -7.70% | -3.22% | -22.50% | 27.40% | 55.32% | 83.79% | 85.88% | -3.03% | $578.1M |
CVRx, Inc.CVRX | 11.1% | 0.00% | 9.23% | -40.08% | -45.12% | -60.00% | -65.20% | -78.12% | -67.47% | -85.28% | -63.59% | $75.4M |
Neuronetics, Inc.STIM | 11.1% | -2.91% | -5.96% | 73.41% | 51.52% | 117.39% | 123.88% | -23.86% | 210.88% | -61.88% | -11.76% | $208.8M |
NeuroPace, Inc.NPCE | 11.1% | 0.07% | -6.78% | -5.27% | 8.84% | -9.13% | -3.77% | 3.62% | 77.15% | -31.12% | 56.06% | $478.3M |
Orchestra BioMed Holdings, Inc.OBIO | 11.1% | -1.29% | 21.82% | 43.32% | 34.67% | 29.16% | 22.37% | 52.27% | -19.03% | -45.11% | 110.20% | $321.0M |
| Theme return | — | -0.13% | 2.38% | 16.42% | 13.31% | 24.22% | 27.60% | 29.35% | 94.58% | 109.26% | 44.18% | — |
| Average | 11.1% | -0.13% | 2.38% | 16.24% | 9.54% | 17.66% | 23.74% | 22.87% | 72.24% | -7.84% | 41.16% | $670.0M |
| Median | 11.1% | -0.44% | 0.00% | 17.08% | 8.84% | 22.66% | 27.40% | 45.03% | 77.15% | -43.39% | 56.06% | $478.3M |
| Std Dev | 0.0% | 3.34% | 8.40% | 30.50% | 25.13% | 60.08% | 55.15% | 77.29% | 119.11% | 91.71% | 86.49% | $774.0M |
| Min | 11.1% | -3.90% | -6.78% | -40.08% | -45.12% | -65.92% | -65.20% | -84.56% | -87.72% | -93.12% | -82.33% | $33.3M |
| Max | 11.1% | 8.53% | 21.82% | 73.41% | 51.52% | 117.39% | 123.88% | 184.91% | 302.56% | 210.15% | 209.96% | $2.71B |
| % Positive Tickers | 33.33% | 44.44% | 66.67% | 77.78% | 55.56% | 66.67% | 66.67% | 66.67% | 22.22% | 55.56% |
About this theme
MedTech Long '25: Neuromodulation & Neurotechnology Devices tracks 9 publicly listed stocks in this theme: ANGO, ARAY, AXGN, BVS, BWAY, CVRX, NPCE, OBIO, STIM. See the constituent table for details.
